ABSTRACT A method for cloning soluble antigen-specific proliferating human T lymphocytes directly from peripheral blood cells of individuals recently primed with the antigen is described. The soluble antigen was keyhole limpet hemocyanin. After expansion in liquid culture, these cells were shown to be antigen specific and to require HLA-DR-histocompatible presenting cells. Re Cell Membrane Markers. Cloned cells were characterized for sheep erythrocyte receptors by a rosette procedure as described (24). In addition, assays for the presence of surface membrane immunoglobulin and complement receptors were performed on the cloned cells as described (24). Other membrane antigens were characterized by indirect immunofluorescence with two mouse monoclonal antibodies. The 3A1 antibody (25) delineates a major peripheral blood T-cell subset; the presence of Ia molecules was assessed by using a heterologous rabbit anti-p23,30 antiserum (gift of Dean Mann). Indirect immunofluorescence to detect cells binding these monoclonal antibodies was performed as described (25).
The technique for cloning mitogen-stimulated T lymphocytes was first described by Rozenszajn et al. (1) and Sredni et al (2) . Since then, major efforts have been made to obtain pure populations of antigen-specific T lymphocytes. Early studies by Ben-Sasson et at (3) demonstrated that enriched populations of proliferating guinea pig T lymphocytes could be obtained by repeated stimulation and selection on antigen-pulsed macrophages. With the discovery and characterization of T-cell growth factor (TCGF) (4) (5) (6) (7) , it has become possible to maintain long-term cultures of antigen-specific (8) (9) (10) (11) and alloreactive (12) (13) (14) (15) (16) murine and human T lymphocytes in vitro. More recently, several laboratories have succeeded in cloning murine or human cells from long-term lines with the help of TCGF either by limiting-dilution techniques (16) (17) (18) (19) or in soft agar (20, 21) . Although these results represent significant progress in the development of monoclonal populations of T lymphocytes, it has not as yet been possible to develop soluble antigenspecific human T-cell clones.
We have described (22, 23) a soft-agar cloning technique which has allowed us to clone cultures of antigen-specific, major histocompatibility complex (MHC)-restricted proliferating mouse T lymphocytes. Extending this technique to the human system, we have now succeeded in generating and expanding soluble antigen-specific proliferating T-lymphocyte clones directly from peripheral blood mononuclear cells (PBMNC) of normal individuals immunized in vivo. We have further demonstrated that these T-cell clones are true clones, are antigen specific, and require HLA-DR-compatible presenting cells together with the appropriate antigen for stimulation. Cell Membrane Markers. Cloned cells were characterized for sheep erythrocyte receptors by a rosette procedure as described (24) . In addition, assays for the presence of surface membrane immunoglobulin and complement receptors were performed on the cloned cells as described (24) . Other membrane antigens were characterized by indirect immunofluorescence with two mouse monoclonal antibodies. The 3A1 antibody (25) delineates a major peripheral blood T-cell subset; the presence of Ia molecules was assessed by using a heterologous rabbit anti-p23,30 antiserum (gift of Dean Mann). Indirect immunofluorescence to detect cells binding these monoclonal antibodies was performed as described (25) .
MATERIALS AND METHODS
TCGF. TCGF was produced as described by Morgan et at (5) and Ruscetti et al (4) Soft-Agar Cloning. After the 5-day period of activation of cells in suspension as described above, cells were collected, washed, and cloned in a two-layer soft-agar system in 30-mm wells (Costar, no. 3566) as described (2, 22, 28) . Briefly, the lower agar layer in each well consisted of 2.5 ml composed of 1.25 ml of EHAA, 0.375 ml of double-strength EHAA, 0.5 ml of heat-inactivated fetal calf serum, 0.375 ml of agar (Noble, Difco, stock agar 3.3% solution, giving a final concentration of 0.5%), and KLH (100 pug/ml). This layer was allowed to equilibrate at 37C in 5% C02/95% air for 4-24 hr prior to use. The upper agar layer consisted of 0.85 ml composed of 0.3 ml of double strength EHAA, 0.15 ml of distilled water, 0.15 ml of fetal calf serum, 0.15 ml of agar (stock agar 1. 8% solution, giving a final concentration of 0. 32%), and 0.1 ml of EHAA containing 2 X 106 PBMNC in the presence or absence of fresh autologous irradiated (4000 R) PBMNC cells (1 x 105). The petri dishes were incubated at 37°C in a humidified atmosphere of 5% CO2/ 95% air. The controls were cultures of PBMNC that had not been primed to the antigen or that were seeded in the agar layer without antigen or with an irrelevant antigen. The cultures were incubated for [3] [4] [5] [6] days during which the development of colonies was observed through an inverted microscope. The number of colonies was estimated by counting colonies of approximately 50 or more cells from six culture plates.
Expansion of Antigen-Specific Colonies. After 3-6 days in the soft agar, colonies were expanded in the following manner. Colonies were picked from soft agar by using a pasteur pipette under observation with a stereoscopic microscope and were placed in 96-well round-bottomed microtiter plates (Linbro) along with 1 x 104 irradiated (4000 R) autologous PBMNC per well as APCs. Cells were cultured in 100 Al of EHAA or RPMI-1640 medium with 20% (vol/vol) TCGF in the presence of antigen (100 jig/ml) for 3-5 days. This was followed by propagation of cultures with 50% TCGF alone. The colonies were repetitively expanded as described above for several months.
Cultures were fed every 3 days by removing 50-70 Al of medium and replacing it with 100 Al of fresh medium containing 50% TCGF. Approximately every 2-3 weeks, colonies that had been expanded every 2-3 days as described above were handled in the following manner: 1 x 104 cells were cultured with antigen (100 ,g/ml), 1 x 105 irradiated autologous PBMNC (APCs), and 20% TCGF in 96-well flat-bottomed microtiter plates (Linbro). Thus, antigen-specific colonies were expanded in two sequential steps. Every 2-3 days, colonies were expanded with 50% TCGF alone, and every 2-3 weeks colonies were expanded with fresh antigen, freshly prepared APCs, and 20% TCGF.
Quantitation of Cell Growth. After variable numbers of days of expansions as described above, aliquots of the colonies were examined for reactivity in a 6-day proliferation assay using [PH~thymidine incorporation (22, 29, 30 (6.7 Ci/mmol; New England Nuclear) and harvested 16-18 hr later by using a MASH II harvester (Microbiological Associates). Incorporation of thymidine was measured by using standard liquid scintillation counting techniques (22, 29, 30) .
Subcloning. For subcloning of the expanded colonies, 200 cells were seeded in soft-agar culture immediately after feeding, by using the same procedure as above (antigen present in the lower layer and the responding T cells and irradiated PBMNC seeded in the upper layer). For further recloning, TCGF (25%) without antigen was present in the lower layer and responding T cells without irradiated presenting cells were seeded in the upper layer. The plating efficiency of subcloning was determined by counting colonies of 50 or more cells from culture plates incubated for 7 days. Subelones derived from each of these two procedures were picked and expanded in liquid culture as described above. RESULTS Establishment of Colonies. PBMNC from the two normal individuals (L. S. and L. D.) who had been immunized with KLH were stimulated in vitro with KLH for 5 days prior to being seeded in soft agar. Four to 6 days after being seeded in soft agar, these lymphocytes developed into colonies containing at least 50 cells each.
Colonies of lymphocytes developed only in the continuous presence of antigen (KLH) which was essential both in the in vitro priming and in the soft-agar layer. No colonies developed in control cultures. The cells proliferated and developed into two types of colonies which were morphologically distinct. The first type (type I) were large colonies of 50-500 cells that developed within the upper agar layer 4-6 days after seeding. These colonies had a compact center and a diffuse periphery. Colonies of the second type (type II) appeared about 2 days later and formed on the exposed surface of the upper agar layer. They were small and flat, contained 50-150 cells, and usually grew above the primary type I colonies. The number of colonies increased with time after in vitro stimulation, reaching a maximum at day 4 for type I and day 5 for type II.
The number of type I colonies formed was proportional to the number of cells seeded in the soft agar over the range 5 X 105 to 4 X 106 cells (Fig. 1) . The slope of the log-log plot of this line was 1, suggesting that each colony derived from one functional cell or unit (31) . In contrast, the development of type II colonies did not show this pattern with regard to the number of cells seeded in agar. Therefore, type I colonies were chosen for additional study.
A critical variable for optimal colony formation was the concentration of antigen used in the lower layer of agar. Too low a concentration of antigen yielded fewer colonies for the same number of cells seeded. The optimal antigen concentrations for type I and type II colonies were 25 and 50 Mg of KLH per ml, respectively. At greater concentrations, there was a plateau for both types of colonies.
Antigen Specificity of the Colonies. Colonies were picked from soft agar at the 50-to 100-cell stage by using a Pasteur pipette and a stereoscopic microscope. . This study reports the development of soluble antigen-specific T-cell clones in man. The T-cell lines developed are true clones, are antigen specific, and require the presence of APCs that are compatible at the DR locus for blast transformation to the relevant antigen. TCGF was essential for both the development and propagation of these antigen-specific Tcell-clones. In this regard, it is uncertain at present whether the antigen-specific clones merely respond to the added TCGF or also produce TCGF themselves in response to antigen. The true clonality of the T-cell lines was established by multiple reclonings at high plating efficiencies. In addition, a direct linear relationship was demonstrated between the number of antigen-specific cloned cells cultured and the magnitude of the blastogenic response during the last 18-24 hr of a 6-day culture in the presence of antigen (Fig. 2) . This is in contrast to studies with uncloned populations of T cells in which at least two T cells have been shown to be involved (31) . In this regard, it is highly likely that, in populations of truly cloned cells, recruitable T cells are no longer present among the cloned cells. The antigen specificity of the T-cell clones was clear from the negligible background-like responses in the absence of antigen and the failure of soluble antigen of noncrossreacting specificity to elicit activation even in the presence of autologous irradiated presenting cells.
The need for APCs in this system is of particular interest. This is compatible with the original observations by Ben-Sasson et al (3) that guinea pig T cells required repeated stimulation with antigen-pulsed macrophages for enrichment of antigenspecific proliferating T cells. In addition, it is directly analogous to the need for cooperation between presenting spleen cells and T-cell clones in the soluble antigen-specific murine T-cell clone model (22) . Although unproven as yet, the functional unit in the agar culture is most likely a macrophage-lymphocyte cluster as described by Lipsky and Rosenthal (32) in the guinea pig.
In this regard, it is thought that the presenting monocytes function in antigen presentation and HLA-DR presentation. However, it is conceivable that other contributions are made by these cells such as the production and secretion of lymphocyte activating factor (LAF) or interleukin 1 (33) which can act by enhancing the proliferation of the T-cell clones under the appropriate circumstances of the presence of specific antigen and HLA-DR compatibility.
Studies demonstrating the requirement for DR-compatible APCs for lymphocyte responses in man are few and often contradictory. Monocytes are absolutely essential for the pokeweed mitogen-induced immunoglobulin production by human lymphocytes. However, there are no apparent allogeneic restrictions to this monocyte requirement (34) . The genetic restrictions for monocytes in antigen-specific antibody responses of human B cells have not been reported. In T-cell blastogenic responses to antigen stimulation, Bergholtz and Thorsby demonstrated the requirement for DR-compatible monocytes (35) . In addition, Kurnick et al. (11) have reported the requirement of APCs with shared HLA-D antigens for the continued proliferation of antigen-specific T cells in the presence of the appropriate soluble antigen. The present study extends this observation to cloned T cells.
Of major importance and interest is the finding that the antigen-specific responses of these human T-cell clones require the presence of APCs which are compatible at the DRw 2 locus. Identity or lack of identity at the HLA-A or B locus was irrelevant.
With regard to the other DR haplotype of the donor of the clone (i.e., DRw 6), it is unclear whether semi-allogeneic APCs which express the DRw 6 haplotype but not the DRw 2 haplotype would be equally effective in presenting antigen to the clone. In fact, it is possible that other gene products not yet tested for or perhaps undescribed at the present time may play a role in the cellular interaction of clones and presenting cells. Such genes coding for these products could be in linkage dysequilibrium with DRw 2.
The development of antigen-specific, genetically restricted, human T-cell clones is of potential importance. Their usefulness ranges from the availability of novel and rapid subtyping with regard to HLA-D typing to the possibility of precisely delineating the biological functions of the proliferating T cell. In addition, characterization of the physical nature and specificity of the antigen receptor of human T cells will be greatly facilitated with the availability of large numbers of these cells. Finally, the development of human T-cell clones with defined antigenic specificities has potentially clinical and therapeutic importance.
